Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BMP1 | P13497 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 18/20 | 0.46 |
| ▸ | CTSD | P07339 | 4/20 | 0.45 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.43 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1674822 | 0.92 | BACE1 (0.47) | BMP1BACE1CTSDDPP4DPP8 | |
| SCHEMBL28605707 | 0.92 | BACE1 (0.47) | BMP1BACE1CTSDDPP4DPP8 | |
| SCHEMBL18797435 | 0.91 | DPP4 (0.52) | BMP1BACE1CTSDDPP4DPP8 | |
| SCHEMBL30421249 | 0.90 | BACE1 (0.53) | BACE1CTSDDPP4DPP8DPP9 | |
| SCHEMBL31410885 | 0.88 | GLO1 (0.42) | BMP1BACE1CTSD | |
| SCHEMBL29590924 | 0.87 | BACE1 (0.54) | BACE1CTSDBACE2 | |
| SCHEMBL31181173 | 0.86 | ENPEP (0.44) | BACE1CTSDBACE2 | |
| SCHEMBL30578958 | 0.86 | BACE1 (0.52) | BACE1CTSDBACE2 | |
| SCHEMBL31344023 | 0.85 | BACE1 (0.49) | BACE1CTSDBACE2 | |
| SCHEMBL31720984 | 0.85 | BACE1 (0.54) | BACE1CTSDBACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |